申请人:Gruenenthal GmbH
公开号:US08232288B2
公开(公告)日:2012-07-31
Substituted benzimidazoles, benzothiazoles and benzoxazoles, processes for their preparation, pharmaceutical compostions containing these compounds and the use of these compounds for treating or inhibiting disorders or disease states mediated at least in part by bradykinin receptor 1 (BR1).
取代苯并咪唑、苯并噻唑和苯并噁唑,它们的制备方法,含有这些化合物的药物组合物以及使用这些化合物治疗或抑制至少部分由布雷金肽受体1(BR1)介导的疾病或疾病状态。